This page is for Health Care Professionals only
Galapagos is proud to be a sponsor of ECCO'23, the biggest event in the inflammatory bowel disease (IBD) calendar!
The ECCO’23 scientific programme includes a wide range of sessions presented by some of the world’s leading specialists in IBD, exploring basic science, conventional medicine, clinical practice and a wealth of intriguing, new data.
Galapagos is excited to be delivering an interactive live symposium, as well as a range of other activities throughout the congress. Don’t miss out – join us as we navigate the path to comprehensive disease control in ulcerative colitis (UC)!
Join our internationally renowned panel as they discuss these topics and share their experiences from the clinic. You will also have the chance to guide the discussion during our live Q&A session. Plus, be sure to catch our experts taking turns in the hot seat! They’ll be answering quick-fire, highly topical questions that clinicians face every day in their practice
This programme is not affiliated with ECCO
Join Professor Stefan Schreiber and Professor Marieke Pierik for the Galapagos-sponsored product theatre session at the 18th Congress of ECCO:
• Want to discover how we could do more for our patients with UC?
• Interested in an expert discussion about a comprehensive approach to UC care in clinical practice?
• Want to explore how JAK inhibition can contribute towards comprehensive disease control in UC?
Join our session on 3 March 2023, 15:00–15:20 CET
GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos
NV.
© 2022 Galapagos NV. All rights reserved.
GL-IBD-FIL-202210-00006
Date of preparation: January 2023
© Copyright 2021 Galapagos NV
The service is temporary unavailable. Please contact your Galapagos Representative
Forgot your PIN? Send an email to omnichannel@glpg.com to retrieve your PIN.
You are about to leave this website and will be redirected to an external website. We are not responsible of that external website’s content. By continuing, you confirm that you have taken note of this.